Model Clo-Sur P.A.D - Biopolymer-based Promotes Hemostasis
Our biopolymer-based Clo-Sur P.A.D. promotes hemostasis through its innovative formulation, structure and positive ionic charge. When Clo-Sur P.A.D. is applied to a wound, its positive charge immediately begins working to rapidly control bleeding. In-vitro laboratory studies have shown this occurs at a faster rate than many competing products1.
-
Most popular related searches
Details
Through the use of Clo-Sur P.A.D., hospitals and clinical facilities have the ability to dramatically reduce time to ambulation and discharge, providing an opportunity for tremendous increases in both patient flow and cost efficiencies:
- Ambulation time for Clo-Sur P.A.D. was an average of 120 minutes as compared to 480 minutes with manual compression alone2
- Clo-Sur P.A.D.’s composition accelerates clotting and is shown to achieve hemostasis in approximately 10 minutes following application during interventional procedures (PCI), when compared to an average mean time of over 16 minutes for manual compression alone2
- When used during diagnostic procedures (DX), 90% of patients reach hemostasis in 10 minutes or less3
- In clinical tests, Clo-Sur P.A.D. can significantly reduce overall complication rates when compared to manual compression alone2
Customer reviews
No reviews were found for Model Clo-Sur P.A.D - Biopolymer-based Promotes Hemostasis. Be the first to review!